ABSTRACT-Stearoyl lysophosphatidylcholine (LPC) exerts protective effect during endotoxemia and in experimental sepsis, but the underlying mechanism is unclear. Here, we demonstrated that stearoyl LPC could block caspase-11-mediated macrophage pyroptosis. In vitro, stearoyl LPC significantly decreased caspase-11 activation and pyroptosis induced by lipopolysaccharide (LPS) plus cholera toxin subunit B independent of the receptor G2A. Stearoyl LPC did not affect LPS uptake by mouse peritoneal macrophages but did significantly inhibit the interaction between LPS and caspase-11. Moreover, stearoyl LPC treatment conferred significant protection against lethal endotoxemia and significantly reduced the release of IL-1a and IL-1b. These findings identify stearoyl LPC as an inhibitor of LPS-mediated caspase-11 activation. This mechanism could explain the protective action of stearoyl LPC in experimental sepsis and endotoxemia.
INTRODUCTION
Endotoxin (lipopolysaccharide: LPS), a major component of Gram-negative bacterial cell walls, is released during Gramnegative infection and can lead to septic shock and death (1) . These lethal responses are mediated by the excessive activation of caspase-11, a newly identified cytosolic receptor for LPS (2) . Upon LPS binding, caspase-11 oligomerizes to a complex, which cleaves pannexin-1 and gasdermin D into their active forms (3) (4) (5) (6) (7) (8) (9) (10) . These events trigger pyroptosis, a proinflammatory form of programmed lytic cell death (8) (9) (10) . Genetic deletion of caspase-11 or its downstream targets prevents pyroptosis and promotes host survival during lethal endotoxemia (3) (4) (5) (6) (7) (8) (9) (10) . Whereas LPS induced activation of caspase-11 induces pyroptosis other known caspase-11 ligands, such as oxidized phospholipids (oxPAPC), induce caspase-11-dependent interleukin-1 release, but not pyroptosis (11) . No specific inhibitor of LPS induces caspase-11 activation has been reported.
Lysophosphatidylcholine (LPC), a major component of oxidized low-density lipoproteins, can be classified according to acyl chain length into several groups, including stearoyl (18:0), lauroyl (12:0), and caproyl LPC (6:0). Stearoyl LPC protects against experimental sepsis and the mechanism was described as dependent on LPC binding to receptor G2A and triggering production of H 2 O 2 , which stimulates neutrophils to eliminate invading pathogens (12) . The same interaction between stearoyl LPC and receptor G2A appears to contribute to the inhibition of high mobility group box-1 protein (HMGB1) release, which could also contribute to the protective actions of stearoyl LPC in experimental sepsis (13) . The protective effects of stearoyl LPC in sepsis models and its structural similarity with oxPAPC led us to hypothesize that stearoyl LPC might inhibit caspase-11 activation and prevent lethality during endotoxemia.
MATERIALS AND METHODS

Antibodies and reagents
Stearoyl LPC was purchased from Sigma-Aldrich (St. Louis, Mo). LPS was from Invivogen (San Diego, Calif) for in vitro and Sigma for in vivo studies. Pam3CSK4 was obtained from Invivogen. Antibody against receptor G2A and Anti-Gsdmd were purchased from Santa Cruz Biotechnology (Dallas, Tex). Antibody against mouse caspase-11 was from Sigma, while anti-E. coli LPS antibody came from Abcam (Cambridge, Mass). Fluorescein isothiocyanate (FITC)-labeled LPS was purchased from Sigma. The liposomal transfection reagent Dotap was obtained from Roche (Indianapolis, Ind). Mouse interleukin (IL)-1a and IL-1b Elisa Kits were from R&D Systems (Minneapolis, Minn).
Macrophage preparation and stimulation
Mouse peritoneal macrophages were isolated and cultured as described (14) . Briefly, C57BL/6 mice (8-10 weeks old) were injected intraperitoneally with 2 mL of sterile 4% thioglycollate broth to elicit peritoneal macrophages. At 48-72 h later, cells were collected by lavage of the peritoneal cavity with 5 mL of sterile 11.6% sucrose. Harvested cells were washed, then re-suspended in RPMI 1640 medium (Gibco) supplemented with 10% heat-inactivated fetal bovine serum (FBS) and antibiotics (Gibco). Peritoneal macrophages were plated in 12-well plates (10 saline (PBS) and treated for 2 h with stearoyl LPC, which had been prepared as before (13) . Cells were washed again with PBS and treated with the combination of LPS (1 mg/mL) and a mixture of cholera toxin subunit B (CTB, 20 mg/ mL) or Dotap, which had been prepared by mixing CTB and Dotap in Optim (Gibco) for 20 min at room temperature. At 16 h after treatment, cells were harvested and total lysates were prepared for analysis using Western blotting an assay for lactate dehydrogenase (LDH). In some experiments, macrophages were treated with LPC without priming. In other experiments, macrophages were treated with anti-G2A antibody (1 mg/mL) alone or with the combination of LPC and anti-G2A antibody (1 mg/mL).
Western blotting
Total cell lysates were prepared and micro-centrifuged. Proteins in the supernatant were extracted using methanol/chloroform, fractionated using 12% sodium dodecyl sulfate polyacrylamide gel electrophoresis, and transferred onto polyvinylidene fluoride membranes (Millipore). Membranes were blotted with antibodies against caspase-11 (1:500) or Gsdmd (1:500). Band density was normalized to levels of b-actin or glyceraldehyde-3-phosphate dehydrogenase on the same blots (1:5,000; Cell Signaling Technology, USA).
Cell death assay
Culture media were harvested and centrifuged to sediment cells; the resulting supernatant was subjected to the LDH Cytotoxicity Assay (Beyotime Biotechnology, China).
Limulus amebocyte lysate (LAL) assay
Isolation of cytosol fraction from mouse peritoneal macrophages was performed as previously described (15) . Briefly, 5 Â 10 6 cells were treated with Stearoyl LPC for 2 h, and then for 2 or 6 h with LPS (1 mg/mL) plus CTB (20 mg/mL) as indicated. After treatment, cells were washed with sterile Dulbecco's Phosphate Buffered Saline (DPBS) then digested with 0.25% trypsin. Digestion was halted by addition of RPMI 1640 supplemented with 10% FBS. Cells were washed three times by DPBS then treated with 300 mL of 0.005% digitonin extraction buffer for 20 min on ice and the supernatant containing cytosol was collected after centrifugation and transferred to a new tube and stored at À808C until analysis using a commercial LAL assay (Xiamen Bio Endo Technology, China).
Flow cytometry
Stearoyl LPC was labeled with an Alexa Fluor 488-conjugated antibody using the Alexa Fluor 488 Labeling Kit (Life Technologies, USA) according to the manufacturer's instructions. Cells were incubated for 1 or 2 h with the resulting stearoyl LPC-488 (20 mM), washed three times with PBS, and then treated as previously (16) to quench extracellular fluorescence. After washing again with PBS, cells were digested with 0.25% trypsin and digestion was halted by adding RPMI 1640 supplemented with 10% FBS. Cell suspensions were centrifuged at 300 g for 5 min, the supernatant was removed. Cell pellets were re-suspended in PBS supplemented with 2% BSA. Re-suspended cells were then analyzed by flow cytometry on a BD FACS Cantoll.
Fluorescence intensity assay
Peritoneal macrophages were plated in 96-well fluorescence plates (10 5 / well), primed and treated as described above. Cells were incubated for 1 or 2 h with LPC-488 (20 mM), washed three times with PBS, and treated as previously described to quench extracellular fluorescence. After washing again with PBS, the intracellular fluorescence intensity was measured using a fluorescence microplate reader (BioTek SynergyTM2, USA). In separate experiments to assess intracellular LPS levels, cells were treated for 2 h with unlabelled stearoyl LPC (20 mM), washed and then incubated for 2 and 6 h with FITC-LPS (1 mg/mL) alone or FITC-LPS plus CTB (20 mg/mL). Cells were washed three times with PBS, and intracellular fluorescence intensity was measured as described above.
Proximity-ligation assay (PLA)
Interaction between LPS and caspase-11 within mouse peritoneal macrophages was analyzed using a proximity-ligation assay kit (Sigma), which examines subcellular localization and protein-protein interactions in situ (17) . Macrophages were cultured in a 6-well glass dish in RPMI 1640, primed for 4 h with Pam3CSK4 (1 mg/mL), then treated for 2 h with stearoyl LPC. Cells were washed, then treated with LPS (4 mg/mL) alone or with LPS plus CTB (40 mg/mL). Cells were fixed with 4% formaldehyde, permeabilized with Triton, and incubated overnight with a pair of primary antibodies from different species: mouse monoclonal 2D7/1 against LPS, and rat monoclonal 17D9 against caspase-11. Subsequently, the proximity-ligation assay was carried out according to the manufacturer's instructions. Briefly, after incubation with primary antibodies, cells were incubated with a combination of oligonucleotide-conjugated probes (secondary antibodies) with mouse as ''plus'' and rat as ''minus.'' Then the ligase, polymerase and oligonucleotides were added to generate circular DNA strands by rolling circle amplification at sites where the probes were bound in proximity. Fluorescently labeled probes were hybridized to complementary sequences in the rolling circle amplification product. Each protein pair generated a spot that could be visualized using fluorescence microscopy. Images were taken using a Leica confocal laser scanning microscope and quantified using Image-J software (Bethesda, Md). Red spots were counted in five randomly selected fields (100Â) and averaged.
Immunofluoresence microscopy
For immunofluorescence staining of spleen tissue, the whole animal was perfused with PBS and fixed in 2% paraformaldehyde. Tissue was then placed in 2% paraformaldehyde for 2 h and then switched to 30% sucrose in distilled water solution for 12 h. Tissue sections (5 mm) were incubated with 2% bovine serum albumin (BSA) in PBS for 1 h, followed by five washes with PBS containing 0.5% BSA (PBB). The samples were then incubated overnight with primary antibodies. TMR red-labeled In Situ Cell Death Detection Reagent kit (Roche, Indianapolis, Ind) was used to detect cell death according to manufacturer's instructions. Samples were washed with PBS before being cover slipped using Gelvatol (23 g polyvinyl alcohol 2000, 50 mL glycerol, 0.1% sodium azide to 100 mL PBS). Imaging conditions were maintained at identical settings within each antibody-labeling experiment with original gating performed using the negative control. Imaging was performed using a Nikon A1 confocal microscope (purchased with 1S10OD019973-01 awarded to Dr Simon C. Watkins).
Mouse model of endotoxic shock
We established the same mouse model of endotoxic shock as described (10) ; in this model, endotoxic shock results from activation of the caspase-11-dependent non-canonical inflammasome. Male or female C57BL/6 mice weighing 20-22 g were primed by intraperitoneal injection with 400 mg/kg LPS (E. coli O111:B4), then challenged 7 h later with 10 mg/kg LPS (E. coli O111:B4). At 30 min before this second LPS injection, mice were subcutaneously injected with stearoyl LPC (10 mg/kg) or PBS vehicle. On each of the following 3 days, stearoyl LPC (10 mg/kg) or PBS was injected at 12-h intervals at different adjacent sites. Survival of the animals was followed for up to 7 days. For plasma IL-1a/b and TMR stain, mice were subcutaneously injected with two dozes stearoyl LPC or PBS at 30 min before and 4 h after the second LPS injection.
Statistical analysis
All data were analyzed using GraphPad Prism (GraphPad Software, La Jolla, Calif). Differences between two groups were assessed for significance using Student's t test. Survival data were compared using the log-rank test. The threshold of significance for all comparisons was P < 0.05. All values are reported as mean AE SD.
RESULT
Stearoyl LPC inhibits intracellular LPS-induced caspase-11 activation and pyroptosis
In order to ensure a uniform baseline level of caspase-11 expression before testing the effects of stearoyl LPC, we primed cells with the Toll-like receptor (TLR) agonists LPS or Pam3CSK4. This priming lead to an increase in intracellular caspase-11 expression as expected (Fig. 1, B, D, and F) . LPS transfection using either Dotap or CTB after priming lead to cell death (Fig. 1, A, C , and E) associated with caspase-11 release (Fig. 1, B , D, and F) from cells. This was suppressed by stearoyl LPC in a concentration-dependent manner. These findings demonstrated that stearoyl LPC inhibits intracellular LPS-induced caspase-11 activation and pyroptosis.
Stearoyl LPC inhibits intracellular LPS-induced cleavage of Gsdmd and release of IL-1a/b
To further confirm that stearoyl LPC inhibits intracellular LPS-induced caspase-11 activation, we measured the Gsdmd cleavage and the IL-1a/b release, both of which are mediated by caspase-11 (9) . Notably, stearoyl LPC inhibited the Gsdmd cleavage ( Fig. 2A) and the IL-1a/b (Fig. 2 , B and C) release in a concentration-dependent manner.
Inhibitory effects of stearoyl LPC do not depend on receptor G2A
As previous studies showed that stearoyl LPC exerts its protective effect during endotoxemia through binding to the G2A receptor, we next determined whether stearoyl LPC inhibits caspase-11 activation through G2A. The inhibitory activity of stearoyl LPC on LPS-induced caspase-11 activation and pyroptosis was not affected by treatment with anti-receptor G2A antibody at the time of intracellular LPS delivery (Fig. 3,  A and B) , indicating that the inhibitory effects of stearoyl LPC on caspase-11 activation do not depend on receptor G2A.
Stearoyl LPC does not block LPS translocation into the cytosol
Since caspase-11 is a cytosolic LPS receptor and the translocation of LPS from extracellular space into the cytosol is required for caspase-11 activation (2), we investigated whether stearoyl LPC affects the translocation of LPS into the cytosol. To test this end, we isolated the cytosolic fraction of stimulated mouse peritoneal macrophages void of cytoplasmic membranes, endosomes, lysosomes, and endoplasmic reticulum, and the measured LPS levels in the cytosolic fraction using the LAL assay. Notably, stearoyl LPC treatment did not alter the cytosolic LPS levels in macrophages exposed to LPS and CTB (Fig. 4, A-D) . Interestingly, using fluorescently labeled stearoyl LPC and flow cytometry we observed that macrophages quickly uptake the fluorophore-labeled stearoyl LPC (Fig. 5, A-D) . These findings indicated that the mechanism of stearoyl LPC suppression of LPS-induced caspase-11 activation does not involve the prevention from LPS translocation into the cytosol, and suggested that stearoyl LPC might prevent caspase-11 activation by acting on an intracellular target. Based on the structural similarity between the LPC and LPS, we postulated that stearoyl LPC might act as a competitive antagonist of LPS interaction with caspase-11. To test this hypothesis, we assessed whether stearoyl LPC could directly inhibit LPS binding to caspase-11 using the proximity ligation assay. Notably, the interaction between caspase-11 and LPS was significantly reduced by stearoyl LPC treatment in mouse peritoneal macrophages primed with Pam3CSK4 and then stimulated with LPS plus CTB (Fig. 6, A and B) . These observations demonstrated that stearoyl LPC inhibits caspase-11 activation by preventing LPS binding to caspase-11. As it is established that caspase-11 mediates LPS-induced shock and lethality, we next determined whether stearoyl LPC exerts a protective effect during lethal endotoxemia. Using a mouse model of endotoxic shock, we found that stearoyl LPC treatment significantly promoted the survival during lethal endotoxemia (Fig. 7) . Moreover, we observed that the cell death in spleen and the release of IL-1a and IL-1b in plasma were significantly attenuated by stearoyl LPC treatment during endotoxemia (Fig. 8) .
DISCUSSION
Elevated level of LPS during sepsis is associated with septic shock and LPS removal from the blood leads to improved outcomes in sepsis (18) . Endotoxin lethality largely depends on the activation of caspase-11 and the subsequent pyroptosis that results in the release of excessive amount of eicosanoids (19) . Upon binding to LPS, the caspase-11 oligomerizes into multiprotein complex and cleaves its substrate gasdermin D, leading to pyroptosis. Here we show that stearoyl LPC, a major component of oxidized low-density lipoprotein, can inhibit caspase-11-dependent pyroptosis through preventing LPS binding to caspase-11. We further show that this inhibition protects against the lethal endotoxemia.
LPC is involved in the pathogenesis of several chronic inflammatory diseases, such as atherosclerosis, psoriasis, asthma, rhinitis, and systemic lupus erythematosus (20) (21) (22) (23) (24) (25) . However in sepsis, an acute systemic inflammatory syndrome, administration of stearoyl LPC improves survival of animals exposed to E. coli or cecal ligation puncture model (12) . Stearoyl LPC has also been shown to suppress the release of HMGB1 from immune cells exposed to LPS (13) and prevents organ dysfunction during experimental polymicrobial sepsis (26) . Our findings indicate that an unrecognized action of LPC is the inhibition of caspase-11. Since it is well-established that caspase-11 drives lethality in the model of endotoxin hypersensitivity used in our studies (10), our results suggest that the inhibition of caspase-11 by LPC accounts, at least in part, for the protective effects of LPC in endotoxemia and sepsis.
To study more precisely how LPC inhibits the caspase-11 activation, we examined the steps leading to LPS-mediated activation of caspase-11. We ruled out an effect of LPC on LPS uptake into the cytosol of macrophages. LPC-induced G2A signaling was showed to promote bacterial clearance and reactive oxygen species production in experimental sepsis (12, 13) . However blockade of receptor G2A did not reverse the LPC-mediated inhibition of cell death following LPS exposure.
In contrast to previous studies that concentrated on LPC action at the cell membrane, our work suggests that a mechanism of action for LPC lies within the cytosol, where LPC binds directly to caspase-11 and thereby blocks its activation and oligomerization in response to LPS. We cannot exclude the possibility that the stearoyl LPC might bind to another target protein, which then inhibits the caspase-11 oligomerization or activation. Together, the present study suggests that stearoyl LPC protects against lethal endotoxemia, at least in part, by inhibiting caspase-11 activation and subsequent pyroptosis.
